Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Dose-escalation, Phase I/Ib Clinical Trial to Assess the Safety and Pharmacokinetics of Clemastine in Preterm Neonates With White Matter Injury (WRAP)

NCT07688746 is registered in ClinicalTrials.gov with Bridget LaMonica Ostrem, M.D., Ph.D. as lead sponsor.

NCT NCT07688746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07688746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Dose-escalation, Phase I/Ib Clinical Trial to Assess the Safety and Pharmacokinetics of Clemastine in Preterm Neonates With White Matter Injury (WRAP)
Lead sponsor
Bridget LaMonica Ostrem, M.D., Ph.D.
Phase
Phase 1
Overall status
Recruiting
Start date
July 26, 2026
Completion date
July 1, 2031
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain injury, fetus and neonate, neonatal brain injury, periventricular leukomalacia, periventricular white matter abnormalities, white matter injury